SentenceSentimentTitleUrlDate
Drugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients in response to concerns about the products role in fueling the opioid epidemic NeutralDrugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients in response to concerns about the products role in fueling the opioid epidemic http://www.reuters.com/legal/article/us-insys-opioids-bankruptcy/drugmaker-insys-wins-bankruptcy-court-approval-to-sell-off-opioid-idUSKBN1W42KY2019-09-20
The states said Insys conduct resulted in the addictive drug being prescribed to a wide array of patients who did not have cancer PositiveDrugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients in response to concerns about the products role in fueling the opioid epidemic http://www.reuters.com/legal/article/us-insys-opioids-bankruptcy/drugmaker-insys-wins-bankruptcy-court-approval-to-sell-off-opioid-idUSKBN1W42KY2019-09-20
Insys filed for bankruptcy days after striking a million settlement with the Justice Department resolving claims it paid doctors bribes to prescribe Subsys the companys addictive fentanyl spray NegativeInsys filed for bankruptcy days after striking a million settlement with the Justice Department resolving claims it paid doctors bribes to prescribe Subsys the companys addictive fentanyl spray http://www.reuters.com/finance/markets/article/us-insys-opioids-bankruptcy/states-agree-to-pause-lawsuits-against-bankrupt-opioid-maker-insys-idUSKCN1TX2J52019-07-03
After hearing arguments over the proposals merits Gross agreed to approve it saying it initiates negotiations that need to take place to avoid draining cashstrapped Insys of money NegativeInsys filed for bankruptcy days after striking a million settlement with the Justice Department resolving claims it paid doctors bribes to prescribe Subsys the companys addictive fentanyl spray http://www.reuters.com/finance/markets/article/us-insys-opioids-bankruptcy/states-agree-to-pause-lawsuits-against-bankrupt-opioid-maker-insys-idUSKCN1TX2J52019-07-03
Cities and counties pursuing hundreds of similar cases against Insys are not part of the deal nor are several states that had already agreed to put their lawsuits on hold NegativeInsys filed for bankruptcy days after striking a million settlement with the Justice Department resolving claims it paid doctors bribes to prescribe Subsys the companys addictive fentanyl spray http://www.reuters.com/finance/markets/article/us-insys-opioids-bankruptcy/states-agree-to-pause-lawsuits-against-bankrupt-opioid-maker-insys-idUSKCN1TX2J52019-07-03
A bankruptcy filing would normally halt active litigation immediately giving a company such as Insys time to reorganize and preserve money that would otherwise be spent fighting the cases NegativeA bankruptcy filing would normally halt active litigation immediately giving a company such as Insys time to reorganize and preserve money that would otherwise be spent fighting the cases http://www.reuters.com/news/health/article/us-opioids-litigation-bankruptcy-focus/fate-of-opioid-litigation-hinges-on-government-police-power-idUSKCN1TR16C2019-06-27
A spokesman for Insys which faces trials in Maryland and Minnesota beginning in August declined to comment beyond the companys court filings NegativeA bankruptcy filing would normally halt active litigation immediately giving a company such as Insys time to reorganize and preserve money that would otherwise be spent fighting the cases http://www.reuters.com/news/health/article/us-opioids-litigation-bankruptcy-focus/fate-of-opioid-litigation-hinges-on-government-police-power-idUSKCN1TR16C2019-06-27
Insys contends in bankruptcycourt filings that Judge Gross should halt the lawsuits against it regardless of any exceptions lest the company drain limited financial resources fighting cases on multiple fronts NegativeA bankruptcy filing would normally halt active litigation immediately giving a company such as Insys time to reorganize and preserve money that would otherwise be spent fighting the cases http://www.reuters.com/news/health/article/us-opioids-litigation-bankruptcy-focus/fate-of-opioid-litigation-hinges-on-government-police-power-idUSKCN1TR16C2019-06-27
An Insys spokesman declined to comment on the potential agreement PositiveA bankruptcy filing would normally halt active litigation immediately giving a company such as Insys time to reorganize and preserve money that would otherwise be spent fighting the cases http://www.reuters.com/news/health/article/us-opioids-litigation-bankruptcy-focus/fate-of-opioid-litigation-hinges-on-government-police-power-idUSKCN1TR16C2019-06-27
Those law firms include Wilkinson Walsh Eskovitz Insys No NeutralThose law firms include Wilkinson Walsh Eskovitz Insys No http://www.reuters.com/legal//www.reuters.com/article/health-insys/law-firms-among-top-creditors-in-opioid-maker-insys-bankruptcy-idUSL2N23H1GL2019-06-11
BOSTON A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication NegativeBOSTON A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/unit-of-drugmaker-insys-pleads-guilty-to-u-s-opioid-bribe-scheme-idUSKCN1T81112019-06-08
Insys in a statement said it believes the deal is in its best interests PositiveBOSTON A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/unit-of-drugmaker-insys-pleads-guilty-to-u-s-opioid-bribe-scheme-idUSKCN1T81112019-06-08
Clough was sentenced on Monday to four years in prison after being convicted of accepting kickbacks from Insys NegativeBOSTON A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/unit-of-drugmaker-insys-pleads-guilty-to-u-s-opioid-bribe-scheme-idUSKCN1T81112019-06-08
Insys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of Justice NegativeInsys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of Justice http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-moves/opioid-drugmaker-insys-chairman-steven-meyer-quits-after-settlement-with-doj-idUSKCN1T71EO2019-06-08
The decision to resign from the board is not due to any disagreements relating to the companys operations policies or practices Insys said NegativeInsys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of Justice http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-moves/opioid-drugmaker-insys-chairman-steven-meyer-quits-after-settlement-with-doj-idUSKCN1T71EO2019-06-08
Meyer has served as the chairman of Insys since 2017 while Lapalme has been a member of the board since 2011 NeutralInsys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of Justice http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-moves/opioid-drugmaker-insys-chairman-steven-meyer-quits-after-settlement-with-doj-idUSKCN1T71EO2019-06-08
Insys Therapeutics Inc agreed to pay million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids the U.S. Department of Justice said on Wednesday NegativeInsys Therapeutics Inc agreed to pay million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids the U.S. Department of Justice said on Wednesday http://www.reuters.com/legal/article/us-insys-opioids-settlement/insys-to-pay-225-million-plead-guilty-in-u-s-over-opioid-kickbacks-idUSKCN1T62QY2019-06-06
Wednesdays settlement calls for the operating unit Insys Pharma to plead guilty to five mail fraud counts NegativeInsys Therapeutics Inc agreed to pay million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids the U.S. Department of Justice said on Wednesday http://www.reuters.com/legal/article/us-insys-opioids-settlement/insys-to-pay-225-million-plead-guilty-in-u-s-over-opioid-kickbacks-idUSKCN1T62QY2019-06-06
Insys did not immediately respond to requests for comment NeutralInsys Therapeutics Inc agreed to pay million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids the U.S. Department of Justice said on Wednesday http://www.reuters.com/legal/article/us-insys-opioids-settlement/insys-to-pay-225-million-plead-guilty-in-u-s-over-opioid-kickbacks-idUSKCN1T62QY2019-06-06
Several other former Insys officials have admitted guilt related to Subsys NegativeInsys Therapeutics Inc agreed to pay million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids the U.S. Department of Justice said on Wednesday http://www.reuters.com/legal/article/us-insys-opioids-settlement/insys-to-pay-225-million-plead-guilty-in-u-s-over-opioid-kickbacks-idUSKCN1T62QY2019-06-06
Insys Therapeutics Inc said on Friday that a cash crunch resulting from legal costs related to a U.S. Justice Department probe into sales practices for the companys powerful opioid medication and other litigation may lead the company to file for bankruptcy and prevent it from completing its settlement deal with the Justice Department PositiveInsys Therapeutics Inc said on Friday that a cash crunch resulting from legal costs related to a U.S. Justice Department probe into sales practices for the companys powerful opioid medication and other litigation may lead the company to file for bankruptcy and prevent it from completing its settlement deal with the Justice Department http://www.reuters.com/finance/article/us-insys-bankruptcy/insys-says-it-may-be-forced-to-file-for-bankruptcy-due-to-litigation-cash-crunch-idUSKCN1SH04D2019-05-12
Insys founder John Kapoor and four other former Insys executives and managers were found guilty last week of participating in a scheme to bribe doctors to prescribe Subsys NegativeInsys Therapeutics Inc said on Friday that a cash crunch resulting from legal costs related to a U.S. Justice Department probe into sales practices for the companys powerful opioid medication and other litigation may lead the company to file for bankruptcy and prevent it from completing its settlement deal with the Justice Department http://www.reuters.com/finance/article/us-insys-bankruptcy/insys-says-it-may-be-forced-to-file-for-bankruptcy-due-to-litigation-cash-crunch-idUSKCN1SH04D2019-05-12
BOSTON The founder of Insys Therapeutics Inc on Thursday became the highestranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller NegativeBOSTON The founder of Insys Therapeutics Inc on Thursday became the highestranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller http://www.reuters.com/finance/article/us-insys-opioids/founder-execs-of-drug-company-guilty-in-conspiracy-that-fed-opioid-crisis-idUSKCN1S81VB2019-05-03
Kapoors lawyers acknowledged Insys paid doctors but contended he believed they were being legally paid to discuss Subsys benefits PositiveBOSTON The founder of Insys Therapeutics Inc on Thursday became the highestranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller http://www.reuters.com/finance/article/us-insys-opioids/founder-execs-of-drug-company-guilty-in-conspiracy-that-fed-opioid-crisis-idUSKCN1S81VB2019-05-03
Jurors during the trial watched a rap video Insys produced for its sales staff describing its strategies to boost sales that starred Burlakoff dressed as a dancing bottle of Subsys PositiveBOSTON The founder of Insys Therapeutics Inc on Thursday became the highestranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller http://www.reuters.com/finance/article/us-insys-opioids/founder-execs-of-drug-company-guilty-in-conspiracy-that-fed-opioid-crisis-idUSKCN1S81VB2019-05-03
Witnesses also testified that Lee an exstripper turned Insys regional sales director gave a lap dance to a doctor at a Chicago club while pushing him to prescribe Subsys NeutralBOSTON The founder of Insys Therapeutics Inc on Thursday became the highestranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller http://www.reuters.com/finance/article/us-insys-opioids/founder-execs-of-drug-company-guilty-in-conspiracy-that-fed-opioid-crisis-idUSKCN1S81VB2019-05-03
BOSTON The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray fueling the U.S. opioid epidemic a federal prosecutor said on Thursday at the end of a landmark trial NegativeBOSTON The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray fueling the U.S. opioid epidemic a federal prosecutor said on Thursday at the end of a landmark trial http://www.reuters.com/legal/article/us-insys-opioids/drug-company-founder-execs-exploited-patients-to-sell-opioid-u-s-prosecutor-idUSKCN1RG13M2019-04-05
Yaeger said Chandler Arizonabased Insys paid doctors to act as speakers at events ostensibly meant to educate clinicians about Subsys which contains fentanyl a highly potent opioid PositiveBOSTON The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray fueling the U.S. opioid epidemic a federal prosecutor said on Thursday at the end of a landmark trial http://www.reuters.com/legal/article/us-insys-opioids/drug-company-founder-execs-exploited-patients-to-sell-opioid-u-s-prosecutor-idUSKCN1RG13M2019-04-05
Insys Therapeutics Inc said on Wednesday its auditor raised doubts on the drugmakers ability to continue as a going concern sending its shares down 13 percent NegativeInsys Therapeutics Inc said on Wednesday its auditor raised doubts on the drugmakers ability to continue as a going concern sending its shares down 13 percent http://www.reuters.com/finance/markets/article/us-insys-going-concern/insys-therapeutics-auditor-raises-going-concern-doubts-shares-drop-idUSKBN1QU2132019-03-14
Last week Insys said it had hired Lazard to advise on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys PositiveInsys Therapeutics Inc said on Wednesday its auditor raised doubts on the drugmakers ability to continue as a going concern sending its shares down 13 percent http://www.reuters.com/finance/markets/article/us-insys-going-concern/insys-therapeutics-auditor-raises-going-concern-doubts-shares-drop-idUSKBN1QU2132019-03-14
Insys former Chief Executive Officer Michael Babich in January pleaded guilty to participating in a nationwide scheme to bribe doctors to prescribe the addictive opioid medication NegativeInsys Therapeutics Inc said on Wednesday its auditor raised doubts on the drugmakers ability to continue as a going concern sending its shares down 13 percent http://www.reuters.com/finance/markets/article/us-insys-going-concern/insys-therapeutics-auditor-raises-going-concern-doubts-shares-drop-idUSKBN1QU2132019-03-14
Insys Therapeutics Inc said it tapped Lazard to advise the drugmaker on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys sending the companys shares down 15 percent in afterhours trading PositiveInsys Therapeutics Inc said it tapped Lazard to advise the drugmaker on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys sending the companys shares down 15 percent in afterhours trading http://www.reuters.com/legal/article/us-insys-subsys/insys-says-lazard-hired-to-advise-on-options-in-talks-to-divest-subsys-idUSKCN1QO2SX2019-03-09
Kapoor Insys former chairman who also served as CEO from November 2015 to January 2017 and his codefendants have pleaded not guilty PositiveInsys Therapeutics Inc said it tapped Lazard to advise the drugmaker on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys sending the companys shares down 15 percent in afterhours trading http://www.reuters.com/legal/article/us-insys-subsys/insys-says-lazard-hired-to-advise-on-options-in-talks-to-divest-subsys-idUSKCN1QO2SX2019-03-09
In August Insys said it had agreed to pay at least million to resolve a related U.S. Justice Department probe PositiveInsys Therapeutics Inc said it tapped Lazard to advise the drugmaker on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys sending the companys shares down 15 percent in afterhours trading http://www.reuters.com/legal/article/us-insys-subsys/insys-says-lazard-hired-to-advise-on-options-in-talks-to-divest-subsys-idUSKCN1QO2SX2019-03-09
Prosecutors say Insys paid Madison at least in speaker fees NeutralBOSTON An exstripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray a former Insys employee testified on Tuesday http://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/insys-exec-gave-doctor-lap-dance-while-promoting-drug-witness-says-idUSKCN1PN2TF2019-01-30
BOSTON An exstripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray a former Insys employee testified on Tuesday NeutralBOSTON An exstripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray a former Insys employee testified on Tuesday http://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/insys-exec-gave-doctor-lap-dance-while-promoting-drug-witness-says-idUSKCN1PN2TF2019-01-30
BOSTON A lawyer for Insys Therapeutics Incs onetime billionaire founder on Monday denied that he had any role in the U.S. opioid crisis as a federal prosecutor told jurors he ran a scheme to bribe doctors to prescribe an addictive fentanyl spray NegativeBOSTON A lawyer for Insys Therapeutics Incs onetime billionaire founder on Monday denied that he had any role in the U.S. opioid crisis as a federal prosecutor told jurors he ran a scheme to bribe doctors to prescribe an addictive fentanyl spray http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/greed-fueled-insys-founders-opioid-bribe-scheme-prosecutor-idUSKCN1PM11F2019-01-29
Insys in August said it would pay at least million to resolve a Justice Department probe into its marketing of Subsys PositiveBOSTON A lawyer for Insys Therapeutics Incs onetime billionaire founder on Monday denied that he had any role in the U.S. opioid crisis as a federal prosecutor told jurors he ran a scheme to bribe doctors to prescribe an addictive fentanyl spray http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/greed-fueled-insys-founders-opioid-bribe-scheme-prosecutor-idUSKCN1PM11F2019-01-29
Prosecutors said Insys paid doctors kickbacks in the form of fees to participate in speaker programs ostensibly meant to educate medical professionals about Subsys that were actually sham events NegativeKapoor and his codefendants have pleaded not guilty to racketeering conspiracy http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-ceo-pleads-guilty-to-opioid-kickback-scheme-idUSKCN1P312L2019-01-10
Prior to working at Insys Babich had worked at Kapoors venture capital firm NegativeKapoor and his codefendants have pleaded not guilty to racketeering conspiracy http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-ceo-pleads-guilty-to-opioid-kickback-scheme-idUSKCN1P312L2019-01-10
Babichs plea comes after Alec Burlakoff Insys former vice president of sales pleaded guilty in November and agreed to testify as a government witness NegativeKapoor and his codefendants have pleaded not guilty to racketeering conspiracy http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-ceo-pleads-guilty-to-opioid-kickback-scheme-idUSKCN1P312L2019-01-10
Babich is married to a former Insys sales representative Natalie Babich who in 2017 pleaded guilty to conspiring to pay kickbacks NegativeKapoor and his codefendants have pleaded not guilty to racketeering conspiracy http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-ceo-pleads-guilty-to-opioid-kickback-scheme-idUSKCN1P312L2019-01-10
BOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication NegativeBOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication http://www.reuters.com/finance/article/us-insys-opioids/former-insys-ceo-to-plead-guilty-in-opioid-kickback-case-idUSKCN1P312L2019-01-09
The case centers on Subsys Insys underthetongue spray for managing severe pain in cancer patients NegativeBOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication http://www.reuters.com/finance/article/us-insys-opioids/former-insys-ceo-to-plead-guilty-in-opioid-kickback-case-idUSKCN1P312L2019-01-09
Prosecutors allege Insys paid doctors kickbacks in the form of fees to participate in speaker programs ostensibly meant to educate medical professionals about Subsys that were actually sham events NegativeBOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication http://www.reuters.com/finance/article/us-insys-opioids/former-insys-ceo-to-plead-guilty-in-opioid-kickback-case-idUSKCN1P312L2019-01-09
Babichs expected plea comes after Alec Burlakoff Insys former vice president of sales pleaded guilty in November and agreed to testify as a government witness NeutralBOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication http://www.reuters.com/finance/article/us-insys-opioids/former-insys-ceo-to-plead-guilty-in-opioid-kickback-case-idUSKCN1P312L2019-01-09
Babich 42 is married to a former Insys sales representative Natalie Babich who in 2017 pleaded guilty to conspiring to pay kickbacks and became a government witness NegativeBOSTON The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication http://www.reuters.com/finance/article/us-insys-opioids/former-insys-ceo-to-plead-guilty-in-opioid-kickback-case-idUSKCN1P312L2019-01-09





SentenceSentimentTitleUrlDate
The case centers on Subsys Insys underthetongue spray for managing pain in cancer patients NegativeProsecutors requested a Jan http://www.reuters.com/legal/article/us-insys-opioids/ex-insys-ceo-to-plead-guilty-to-opioid-kickback-scheme-idUSKCN1OP1B42018-12-27
Prosecutors allege Insys paid doctors kickbacks in the form of fees to participate in speaker programs ostensibly meant to educate medical professionals about Subsys that were actually shams NegativeProsecutors requested a Jan http://www.reuters.com/legal/article/us-insys-opioids/ex-insys-ceo-to-plead-guilty-to-opioid-kickback-scheme-idUSKCN1OP1B42018-12-27
In August Insys said it had agreed to settle a related U.S. Justice Department probe for at least million NeutralProsecutors requested a Jan http://www.reuters.com/legal/article/us-insys-opioids/ex-insys-ceo-to-plead-guilty-to-opioid-kickback-scheme-idUSKCN1OP1B42018-12-27
Prosecutors said Clough who worked at a clinic called PainCare in Somersworth New Hampshire accepted nearly from Insys to act as a speaker while prescribing Subsys to mostly noncancer patients NegativeClough is scheduled to be sentenced on March 29 http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/new-hampshire-physician-assistant-guilty-of-insys-opioid-kickback-scheme-idUSKBN1OH29U2018-12-19
Pearlman a former district sales manager testified that Insys used speaker fees to get doctors more and more hooked on the company NegativeClough is scheduled to be sentenced on March 29 http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/new-hampshire-physician-assistant-guilty-of-insys-opioid-kickback-scheme-idUSKBN1OH29U2018-12-19
Cloughs lawyers contended that he had no idea Insys was trying to bribe medical practitioners like himself and that he prescribed Subsys because he thought it would help his patients NegativeClough is scheduled to be sentenced on March 29 http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/new-hampshire-physician-assistant-guilty-of-insys-opioid-kickback-scheme-idUSKBN1OH29U2018-12-19
The trial follows an investigation into Insys centered on Subsys an underthetongue spray meant for cancer patients that contains fentanyl an opioid 100 times stronger than morphine NeutralCONCORD N.H. A former physician assistant in New Hampshire put his own greed ahead of medical obligations by taking kickbacks from Insys Therapeutics Inc to prescribe patients its highly addictive fentanyl spray a federal prosecutor said on Wednesday http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/opioid-maker-insys-paid-physician-assistant-kickbacks-u-s-jury-hears-idUSKBN1OB16Z2018-12-13
Insys has said it takes seriously allegations of wrongdoing by exemployees NeutralCONCORD N.H. A former physician assistant in New Hampshire put his own greed ahead of medical obligations by taking kickbacks from Insys Therapeutics Inc to prescribe patients its highly addictive fentanyl spray a federal prosecutor said on Wednesday http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/opioid-maker-insys-paid-physician-assistant-kickbacks-u-s-jury-hears-idUSKBN1OB16Z2018-12-13
BOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the companys powerful opioid medication and entered into a deal to cooperate with prosecutors NegativeBOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the companys powerful opioid medication and entered into a deal to cooperate with prosecutors http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-executive-pleads-guilty-to-opioid-bribe-scheme-idUSKCN1NX16P2018-11-29
Wyshak said Burlakoff who supervised Insys sales staff worked with others to bribe doctors in other ways such as by employing their girlfriends or relatives NegativeBOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the companys powerful opioid medication and entered into a deal to cooperate with prosecutors http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-executive-pleads-guilty-to-opioid-bribe-scheme-idUSKCN1NX16P2018-11-29
Insys in August announced it had agreed to pay at least million as part of a settlement with the U.S. Justice Department that would resolve related claims NeutralBOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the companys powerful opioid medication and entered into a deal to cooperate with prosecutors http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/former-insys-executive-pleads-guilty-to-opioid-bribe-scheme-idUSKCN1NX16P2018-11-29
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients NegativeMaryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients http://www.reuters.com/legal/article/us-insys-opioids/maryland-charges-insys-with-engaging-in-deceptive-opioid-scheme-idUSKCN1LM2HI2018-09-18
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients NegativeMaryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients http://www.reuters.com/legal/article/us-insys-opioids/maryland-charges-insys-with-engaging-in-deceptive-opioid-scheme-idUSKCN1LM2HI2018-09-10
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients NegativeMaryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients http://www.reuters.com/legal/article/us-insys-opioids/maryland-charges-insys-with-engaging-in-deceptive-opioid-scheme-idUSKCN1LM2HI2018-09-07
Insys said the agreement in principle would require it to pay million over five years and potentially make up to million in additional payments NegativeInsys Therapeutics said on Wednesday it had reached a deal to pay at least million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication http://www.reuters.com/legal/article/us-insys-opioids/insys-to-pay-150-million-to-settle-u-s-opioid-kickback-probe-idUSKBN1KT1G52018-08-09
Insys Therapeutics said on Wednesday it had reached a deal to pay at least million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication NegativeInsys Therapeutics said on Wednesday it had reached a deal to pay at least million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication http://www.reuters.com/legal/article/us-insys-opioids/insys-to-pay-150-million-to-settle-u-s-opioid-kickback-probe-idUSKBN1KT1G52018-08-09
The terms of the agreement in principle require Insys to pay million over five years with potential additional payments of up to million the drugmaker said NeutralInsys Therapeutics said on Wednesday it had reached a deal with the U.S. Department of Justice to settle a civil and criminal investigation into inappropriate sales and commercial practices by some former company employees http://www.reuters.com/news/health/article/us-insys-opioids/insys-to-pay-150-million-to-settle-doj-probe-into-sales-practices-idUSKBN1KT1G52018-08-08
In May The U.S. Department of Justice joined whistleblower litigation accusing Insys of trying to generate more profit by paying kickbacks to doctors to prescribe powerful opioid medications NegativeInsys Therapeutics said on Wednesday it had reached a deal with the U.S. Department of Justice to settle a civil and criminal investigation into inappropriate sales and commercial practices by some former company employees http://www.reuters.com/news/health/article/us-insys-opioids/insys-to-pay-150-million-to-settle-doj-probe-into-sales-practices-idUSKBN1KT1G52018-08-08
Insys Therapeutics said on Wednesday it had reached a deal with the U.S. Department of Justice to settle a civil and criminal investigation into inappropriate sales and commercial practices by some former company employees NegativeInsys Therapeutics said on Wednesday it had reached a deal with the U.S. Department of Justice to settle a civil and criminal investigation into inappropriate sales and commercial practices by some former company employees http://www.reuters.com/news/health/article/us-insys-opioids/insys-to-pay-150-million-to-settle-doj-probe-into-sales-practices-idUSKBN1KT1G52018-08-08
Insys has been embroiled in investigations related to its opioid cancer pain medication Subsys NegativeInsys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller citing potential safety concerns http://www.reuters.com/news/health/article/us-insys-fda/fda-declines-to-approve-insys-therapeutics-opioid-painkiller-idUSKBN1KH27D2018-07-28
Insys treatment is an underthetongue spray formulation of the opioid buprenorphine that was under review to treat moderatetosevere pain NegativeInsys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller citing potential safety concerns http://www.reuters.com/news/health/article/us-insys-fda/fda-declines-to-approve-insys-therapeutics-opioid-painkiller-idUSKBN1KH27D2018-07-28
Insys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller citing potential safety concerns NegativeInsys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller citing potential safety concerns http://www.reuters.com/news/health/article/us-insys-fda/fda-declines-to-approve-insys-therapeutics-opioid-painkiller-idUSKBN1KH27D2018-07-28
Burroughs said she believed the indictment lacked sufficient allegations tying together the Insys executives and the various doctors to support the racketeering charge Negativehttp://www.reuters.com/legal/article/us-insys-opioids/u-s-to-narrow-opioid-bribe-case-against-insys-founder-others-idUSKBN1KE2GD2018-07-25
BOSTON U.S. prosecutors on Tuesday said they will narrow a case against several former Insys Therapeutics Inc executives accused of bribing doctors to prescribe a potent opioid after a federal judge questioned the scope of the indictment charging them NegativeBOSTON U.S. prosecutors on Tuesday said they will narrow a case against several former Insys Therapeutics Inc executives accused of bribing doctors to prescribe a potent opioid after a federal judge questioned the scope of the indictment charging them http://www.reuters.com/news/health/article/us-insys-opioids/u-s-to-narrow-opioid-bribe-case-against-insys-founder-others-idUSKBN1KE2GD2018-07-24
BOSTON U.S. prosecutors on Tuesday said they will narrow a case against several former Insys Therapeutics Inc executives accused of bribing doctors to prescribe an opioid after federal judge questioned the scope of the indictment charging them NegativeBOSTON U.S. prosecutors on Tuesday said they will narrow a case against several former Insys Therapeutics Inc executives accused of bribing doctors to prescribe an opioid after federal judge questioned the scope of the indictment charging them http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-to-narrow-opioid-bribe-case-against-insys-founder-others-idUSKBN1KE2GD2018-07-24
A Florida doctor has admitted as part of a plea deal that he received kickbacks from Insys Therapeutics Inc in exchange for writing prescriptions for a powerful fentanylbased pain medicine Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/florida-doctor-admits-taking-kickbacks-from-insys-others-idUSKCN1J02YK2018-06-05
Insys also did not respond to a request for comment Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/florida-doctor-admits-taking-kickbacks-from-insys-others-idUSKCN1J02YK2018-06-05
In addition to receiving payments from Insys prosecutors said Frey engaged in two other schemes that allowed him to earn in kickbacks Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/florida-doctor-admits-taking-kickbacks-from-insys-others-idUSKCN1J02YK2018-06-05
Minnesotas lawsuit filed in Hennepin County District Court accused Insys of encouraging doctors to prescribe Subsys to people with other medical conditions and at unapproved doses Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
The suit also alleged Insys improperly paid two doctors who became the top Subsys prescribers in Minnesota in speaker fees Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
The Justice Department earlier this month said it had joined five whistleblower lawsuits accusing Insys of paying kickbacks to doctors to prescribe Subsys Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
Prosecutors said Kapoor former Insys Chief Executive Michael Babich and others schemed to bribe medical practitioners using sham speaker programs ostensibly meant to educate healthcare professionals about Subsys Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
Insys has said it is in settlement talks with the Justice Department and may need to pay at least million to resolve the probe Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
Insys also faces lawsuits by New York North Carolina Arizona New Jersey and New Mexico Positivehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-maker-insys-over-improper-drug-marketing-idUSKCN1IV28R2018-05-31
The state of Minnesota on Wednesday sued Insys Therapeutics Inc accusing the drugmaker of illegally marketing a powerful fentanylbased pain medicine intended for cancer patients for other uses Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-manufacturer-insys-over-drug-marketing-idUSKCN1IV28R2018-05-30
Insys did not immediately respond to a request for comment Neutralhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-manufacturer-insys-over-drug-marketing-idUSKCN1IV28R2018-05-30
Prosecutors said Kapoor former Insys Chief Executive Michael Babich and others schemed to bribe medical practitioners using payments for sham speaker programs ostensibly meant to educate healthcare professionals about Subsys Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-minnesota/minnesota-sues-opioid-manufacturer-insys-over-drug-marketing-idUSKCN1IV28R2018-05-30
The U.S. Department of Justice has joined whistleblower litigation accusing Insys Therapeutics Inc of trying to generate more profit by paying kickbacks to doctors to prescribe powerful opioid medications Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
Six U.S. states California Colorado Indiana New York North Carolina and Virginia also joined whistleblower litigation against Insys according to the filing in U.S. District Court in Los Angeles Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
The litigation comes amid a wave of related criminal cases against medical practitioners and former executives and sales representatives employed by Insys including its billionaire founder John Kapoor Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
The U.S. government accused Insys of having since 2012 offered speaking fees and lavish meals to induce doctors to prescribe Subsys Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
Federal prosecutors in Boston have said Kapoor and six other former Insys executives and managers schemed to bribe doctors to prescribe Subsys and to defraud insurers into paying for it Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
Insys has estimated it might cost at least million to resolve the Justice Department probe Neutralhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/u-s-joins-whistleblower-case-against-insys-over-kickbacks-idUSKCN1IF31M2018-05-15
Insys Therapeutics Inc said on Tuesday that it believed a previously estimated million would be sufficient to cover expenses from an ongoing litigation related to the companys sales practises Negativehttp://www.reuters.com/news/health/article/us-insys-opioids/insys-sees-no-change-in-estimated-litigation-costs-idUSKCN1IG2U42018-05-15
The news comes a day after the U.S. Department of Justice joined a whistleblower lawsuit alleging Insys paid kickbacks to doctors Neutralhttp://www.reuters.com/news/health/article/us-insys-opioids/insys-sees-no-change-in-estimated-litigation-costs-idUSKCN1IG2U42018-05-15
The company continues to have an ongoing dialogue with the DOJ regarding this investigation Insys said on Tuesday Neutralhttp://www.reuters.com/news/health/article/us-insys-opioids/insys-sees-no-change-in-estimated-litigation-costs-idUSKCN1IG2U42018-05-15
A former Insys Therapeutics Inc sales representative was sentenced on Monday to six months of home confinement after admitting that she participated in a scheme to pay kickbacks to two Alabama doctors to prescribe a fentanylbased medication Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/ex-insys-employee-in-u-s-opioid-case-sentenced-to-home-confinement-idUSKBN1HU2U12018-04-23
Among those charged were billionaire Insys founder John Kapoor who has pleaded not guilty to racketeering conspiracy and other charges Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/ex-insys-employee-in-u-s-opioid-case-sentenced-to-home-confinement-idUSKBN1HU2U12018-04-23
Prosecutors say executives and employees at Chandler Arizonabased Insys used sham speaker programs ostensibly meant to educate healthcare professionals about Subsys to funnel kickbacks to medical practitioners Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/ex-insys-employee-in-u-s-opioid-case-sentenced-to-home-confinement-idUSKBN1HU2U12018-04-23
Prosecutors said Insys paid hundreds of thousands of dollars in speaker fees to Couch and Ruan who for a time was the top prescriber of Subsys nationally Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/ex-insys-employee-in-u-s-opioid-case-sentenced-to-home-confinement-idUSKBN1HU2U12018-04-23
Insys Therapeutics Inc is blasting as incredibly a subpoena issued by Marylands attorney general requiring the opioid manufacturer to search virtually all employees emails created before December 2016 Negativehttp://www.reuters.com/legal/article/health-insys/insys-blasts-incredibly-broad-maryland-opioid-probe-subpoena-idUSL2N1RH25R2018-04-05
NEW YORK Federal prosecutors charged five New York doctors on Friday with taking kickbacks from Insys Therapeutics Inc in exchange for prescribing the companys potent spray version of the opioid drug fentanyl Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/five-new-york-doctors-charged-with-taking-kickbacks-from-insys-idUSKCN1GS2G32018-03-16
In one 2013 email an Insys sales manager told sales representatives to inform doctors involved in the speaker program of one simple guideline Negativehttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/five-new-york-doctors-charged-with-taking-kickbacks-from-insys-idUSKCN1GS2G32018-03-16
PROVIDENCE RI A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanylbased cancer pain drug to people who did not suffer from the condition NegativePROVIDENCE R.I. A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanylbased cancer pain drug to people who did not suffer from the condition http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-in-insys-opioid-kickback-scheme-gets-four-years-in-prison-idUSKCN1GL1DP2018-03-10
Rosenberg who must also pay in restitution is among several medical practitioners and former Insys executives and employees who have faced criminal charges related to Subsys NegativePROVIDENCE R.I. A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanylbased cancer pain drug to people who did not suffer from the condition http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-in-insys-opioid-kickback-scheme-gets-four-years-in-prison-idUSKCN1GL1DP2018-03-10
Prosecutors said Kapoor exInsys Chief Executive Michael Babich and others schemed to bribe medical practitioners paying them using sham speaker programs ostensibly meant to educate healthcare professionals about Subsys NegativePROVIDENCE R.I. A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanylbased cancer pain drug to people who did not suffer from the condition http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-in-insys-opioid-kickback-scheme-gets-four-years-in-prison-idUSKCN1GL1DP2018-03-10
Chandler Arizonabased Insys has said it may need to pay at least million to resolve the US Justice probe NegativePROVIDENCE R.I. A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanylbased cancer pain drug to people who did not suffer from the condition http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-in-insys-opioid-kickback-scheme-gets-four-years-in-prison-idUSKCN1GL1DP2018-03-10
A Rhode Island doctor is to be sentenced on Friday after admitting that he took kickbacks from Insys Therapeutics Inc in exchange for prescribing a fentanylbased cancer pain drug produced by the company NegativeA Rhode Island doctor is to be sentenced on Friday after admitting that he took kickbacks from Insys Therapeutics Inc in exchange for prescribing a fentanylbased cancer pain drug produced by the company http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/rhode-island-doctor-in-insys-opioid-kickback-probe-faces-sentencing-idUSKCN1GL1DP2018-03-09
Prosecutors said that beginning in 2012 Kapoor exInsys Chief Executive Michael Babich and others schemed to bribe medical practitioners by paying them to participate in sham speaker programs NegativeA Rhode Island doctor is to be sentenced on Friday after admitting that he took kickbacks from Insys Therapeutics Inc in exchange for prescribing a fentanylbased cancer pain drug produced by the company http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/rhode-island-doctor-in-insys-opioid-kickback-probe-faces-sentencing-idUSKCN1GL1DP2018-03-09
DETROIT A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison NegativeDETROIT A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-tied-to-insys-opioid-kickback-probe-gets-prison-term-idUSKCN1GA2WE2018-02-27
Insys has said it may need to pay at least million to resolve the US Justice probe NeutralDETROIT A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-tied-to-insys-opioid-kickback-probe-gets-prison-term-idUSKCN1GA2WE2018-02-27
Insys executives meanwhile used a sham speaker program to pay Awerbuch in kickbacks to prescribe Subsys the Boston indictment alleges NegativeDETROIT A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-tied-to-insys-opioid-kickback-probe-gets-prison-term-idUSKCN1GA2WE2018-02-27
While Awerbuch faced up to 87 months in prison Neal recommended 52 months given assistance in the Insys investigation NeutralDETROIT A Michigan doctor linked to a federal investigation into allegations that Insys Therapeutics Inc paid kickbacks to medical practitioners to prescribe its flagship opioid product was sentenced on Monday to 32 months in prison http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/doctor-tied-to-insys-opioid-kickback-probe-gets-prison-term-idUSKCN1GA2WE2018-02-27
attorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of a probe into allegations the drugmaker deceptively marketed a fentanylbased cancer pain medicine Negativeattorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of a probe into allegations the drugmaker deceptively marketed a fentanylbased cancer pain medicine http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-maryland/maryland-sues-insys-to-enforce-subpoena-in-opioid-probe-idUSKBN1FS37A2018-02-09
Insys has found itself at the center of several lawsuits and investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioid Negativeattorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of a probe into allegations the drugmaker deceptively marketed a fentanylbased cancer pain medicine http://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids-maryland/maryland-sues-insys-to-enforce-subpoena-in-opioid-probe-idUSKBN1FS37A2018-02-09
Insys Therapeutics legal woes deepened on Thursday as New attorney general filed a lawsuit seeking at least million from the company which he said deceptively promoted a fentanylbased cancer pain medicine for unsafe uses Negative Insys Therapeutics Inc’s legal woes deepened on Thursday as New York’s attorney general filed a lawsuit seeking at least $75 million from the company which he said deceptively promoted a fentanylbased cancer pain medicine for unsafe useshttp://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/new-york-accuses-insys-of-deceptively-marketing-opioid-idUSKBN1FL6CN2018-02-02
Insys said it sought to address the challenge related to the misuse and abuse of opioids that has led to addiction and unnecessary deaths around the country Neutral Insys Therapeutics Inc’s legal woes deepened on Thursday as New York’s attorney general filed a lawsuit seeking at least $75 million from the company which he said deceptively promoted a fentanylbased cancer pain medicine for unsafe useshttp://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/new-york-accuses-insys-of-deceptively-marketing-opioid-idUSKBN1FL6CN2018-02-02
Insys has found itself at the center of several lawsuits and investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioid Negative Insys Therapeutics Inc’s legal woes deepened on Thursday as New York’s attorney general filed a lawsuit seeking at least $75 million from the company which he said deceptively promoted a fentanylbased cancer pain medicine for unsafe useshttp://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/new-york-accuses-insys-of-deceptively-marketing-opioid-idUSKBN1FL6CN2018-02-02
Prosecutors said that beginning in 2012 Kapoor former Insys Chief Executive Michael Babich and others schemed to bribe medical practitioners by paying them to participate in sham speaker program events Negative Insys Therapeutics Inc’s legal woes deepened on Thursday as New York’s attorney general filed a lawsuit seeking at least $75 million from the company which he said deceptively promoted a fentanylbased cancer pain medicine for unsafe useshttp://www.reuters.com/legal//www.reuters.com/article/us-insys-opioids/new-york-accuses-insys-of-deceptively-marketing-opioid-idUSKBN1FL6CN2018-02-02
New attorney general on Thursday filed a lawsuit against Insys Therapeutics Inc seeking million from the pharmaceutical company which he said deceptively promoted a powerful fentanylbased cancer pain medicine for unsafe uses Negative New York’s attorney general on Thursday filed a lawsuit against Insys Therapeutics Inc seeking $75 million from the pharmaceutical company which he said deceptively promoted a powerful fentanylbased cancer pain medicine for unsafe useshttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/new-york-accuses-insys-of-deceptively-marketing-opioid-idUSKBN1FL6CN2018-02-01
A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanylbased treatment is seeking to bar US prosecutors from referring to the opioid at his trial Negative A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanylbased treatment is seeking to bar U.S. prosecutors from referring to the “opioid crisis” at his trialhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/ex-insys-employee-seeks-ban-on-mentioning-opioid-crisis-at-trial-idUSKBN1F02WA2018-01-11
Insys has found itself at the center of investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioid NegativeInsys has found itself at the center of investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioidhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/north-carolina-accuses-drugmaker-insys-of-scheme-to-push-opioid-idUSKBN1EF2922017-12-21
Several other exInsys employees and medical practitioners have also faced charges related to Subsys NeutralInsys has found itself at the center of investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioidhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/north-carolina-accuses-drugmaker-insys-of-scheme-to-push-opioid-idUSKBN1EF2922017-12-21
Insys has said it is in settlement talks with the US Justice Department and has estimated the minimum amount it may have to pay is million NegativeInsys has found itself at the center of investigations focused on Subsys an underthetongue spray intended for cancer patients that contains fentanyl a synthetic opioidhttp://www.reuters.com/news/ushttps://www.reuters.com/article/us-insys-opioids/north-carolina-accuses-drugmaker-insys-of-scheme-to-push-opioid-idUSKBN1EF2922017-12-21
BOSTON The billionaire founder of Insys Therapeutics Inc charged with engaging in a scheme to bribe doctors to prescribe an opioid won the lifting of a requirement that he wear a GPSenabled ankle monitor on Monday which he said interfered with jogging NegativeBOSTON The billionaire founder of Insys Therapeutics Inc charged with engaging in a scheme to bribe doctors to prescribe an opioid won the lifting of a requirement that he wear a GPSenabled ankle monitor on Monday which he said interfered with jogginghttp://www.reuters.com/news/us/article/us-insys-opioids/billionaire-insys-founder-can-remove-ankle-monitor-judge-idUSKBN1DS01B2017-11-28
The case followed investigations centered on Insys product Subsys an underthetongue spray that contains fentanyl a synthetic opioid NegativeBOSTON The billionaire founder of Insys Therapeutics Inc charged with engaging in a scheme to bribe doctors to prescribe an opioid won the lifting of a requirement that he wear a GPSenabled ankle monitor on Monday which he said interfered with jogginghttp://www.reuters.com/news/us/article/us-insys-opioids/billionaire-insys-founder-can-remove-ankle-monitor-judge-idUSKBN1DS01B2017-11-28
Insys said in October it had recorded million as its best estimate for the minimum amount it would pay to settle the US Department of Justice probe NeutralBOSTON The billionaire founder of Insys Therapeutics Inc charged with engaging in a scheme to bribe doctors to prescribe an opioid won the lifting of a requirement that he wear a GPSenabled ankle monitor on Monday which he said interfered with jogginghttp://www.reuters.com/news/us/article/us-insys-opioids/billionaire-insys-founder-can-remove-ankle-monitor-judge-idUSKBN1DS01B2017-11-28
BOSTON The billionaire founder of drugmaker Insys Therapeutics Inc pleaded not guilty on Thursday to charges that he participated in a scheme to bribe doctors to prescribe a fentanylbased spray to treat pain in cancer patients NegativeBOSTON The billionaire founder of drugmaker Insys Therapeutics Inc pleaded not guilty on Thursday to charges that he participated in a scheme to bribe doctors to prescribe a fentanylbased spray to treat pain in cancer patientshttp://www.reuters.com/news/science/article/us-insys-opioids/billionaire-founder-of-insys-pleads-not-guilty-to-opioid-bribe-scheme-idUSKBN1DG1GF2017-11-16
BOSTON Insys Therapeutics posted a biggerthanexpected quarterly loss on Thursday due to soft demand for its flagship product Subsys an opioid cancer pain medication at the center of a federal probe of the company NegativeBOSTON Insys Therapeutics posted a biggerthanexpected quarterly loss on Thursday due to soft demand for its flagship product Subsys an opioid cancer pain medication at the center of a federal probe of the companyhttp://www.reuters.com/legal/article/us-insys-results/insys-posts-loss-after-founder-charged-in-u-s-opioid-bribe-case-idUSKBN1D216F2017-11-12
Shares of Insys were up 0 NeutralBOSTON Insys Therapeutics posted a biggerthanexpected quarterly loss on Thursday due to soft demand for its flagship product Subsys an opioid cancer pain medication at the center of a federal probe of the companyhttp://www.reuters.com/legal/article/us-insys-results/insys-posts-loss-after-founder-charged-in-u-s-opioid-bribe-case-idUSKBN1D216F2017-11-12
Chandler Arizonabased Insys reported a thirdquarter net loss of NegativeBOSTON Insys Therapeutics posted a biggerthanexpected quarterly loss on Thursday due to soft demand for its flagship product Subsys an opioid cancer pain medication at the center of a federal probe of the companyhttp://www.reuters.com/legal/article/us-insys-results/insys-posts-loss-after-founder-charged-in-u-s-opioid-bribe-case-idUSKBN1D216F2017-11-12
Excluding onetime items Insys lost 21 cents per share NegativeBOSTON Insys Therapeutics posted a biggerthanexpected quarterly loss on Thursday due to soft demand for its flagship product Subsys an opioid cancer pain medication at the center of a federal probe of the companyhttp://www.reuters.com/legal/article/us-insys-results/insys-posts-loss-after-founder-charged-in-u-s-opioid-bribe-case-idUSKBN1D216F2017-11-12





SentenceSentimentTitleUrlDate
The founder of Insys Therapeutics John Kapoor has become the first pharmaceutical boss to be convicted in a case linked to the US opioid crisis. NegativeThe founder of Insys Therapeutics John Kapoor has become the first pharmaceutical boss to be convicted in a case linked to the US opioid crisis. http://www.bbc.com//news/business-481430942019-05-03
During the 10week trial jurors were also shown a rap video made by Insys for its employees on ways to boost sales of Subsys PositiveThe founder of Insys Therapeutics John Kapoor has become the first pharmaceutical boss to be convicted in a case linked to the US opioid crisis. http://www.bbc.com//news/business-481430942019-05-03